GATA2 and acute myeloid leukemia: Secondly, we observed increased CEBPA binding to the G2DHE in CebpaDM AML compared to normal progenitors and found that deletion or mutagenesis of the CEBPA-bound region of the enhancer resulted in lower expression of Gata2 in CebpaDM cells.